"Glycosylation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The chemical or biochemical addition of carbohydrate or glycosyl groups to other chemicals, especially peptides or proteins. Glycosyl transferases are used in this biochemical reaction.
| Descriptor ID |
D006031
|
| MeSH Number(s) |
G02.111.158.812 G02.607.299 G03.191.812
|
| Concept/Terms |
Protein Glycosylation- Protein Glycosylation
- Glycosylation, Protein
- Glycosylations, Protein
- Protein Glycosylations
|
Below are MeSH descriptors whose meaning is more general than "Glycosylation".
Below are MeSH descriptors whose meaning is more specific than "Glycosylation".
This graph shows the total number of publications written about "Glycosylation" by people in this website by year, and whether "Glycosylation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 3 | 3 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2006 | 0 | 2 | 2 |
| 2007 | 0 | 3 | 3 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 3 | 3 |
| 2010 | 1 | 5 | 6 |
| 2011 | 0 | 3 | 3 |
| 2012 | 0 | 3 | 3 |
| 2013 | 0 | 3 | 3 |
| 2014 | 0 | 3 | 3 |
| 2015 | 0 | 3 | 3 |
| 2016 | 0 | 7 | 7 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 2 | 2 |
| 2020 | 0 | 9 | 9 |
| 2021 | 0 | 3 | 3 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 5 | 5 |
| 2024 | 0 | 6 | 6 |
| 2025 | 0 | 3 | 3 |
| 2026 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glycosylation" by people in Profiles.
-
GALNT6 localization is associated with gland-forming architecture and morphological differentiation in luminal A breast cancer. Biochim Biophys Acta Gen Subj. 2026 Oct; 1870(10):130975.
-
TUSC3 serves as a rate-limiting gatekeeper of a glycan-mediated ER triage checkpoint for BMP4/Dpp. Cell Rep. 2026 Jul 28; 45(7):117628.
-
O-GlcNAcylation as a Metabolic Integrator in Cardiovascular Physiology and Disease. Int J Mol Sci. 2026 May 22; 27(11).
-
Identification of Hepatic-like EPO as a Cause of Polycythemia. N Engl J Med. 2025 May 01; 392(17):1684-1697.
-
Bi-allelic UGGT1 variants cause a congenital disorder of glycosylation. Am J Hum Genet. 2025 05 01; 112(5):1139-1157.
-
Causes of mortality in the congenital disorders of glycosylation. Mol Genet Metab. 2025 Mar; 144(3):109052.
-
ClC-Kb pore mutation disrupts glycosylation and triggers distal tubular remodeling. JCI Insight. 2024 11 22; 9(22).
-
Cardiomyopathy, an uncommon phenotype of congenital disorders of glycosylation: Recommendations for baseline screening and follow-up evaluation. Mol Genet Metab. 2024 08; 142(4):108513.
-
Frontiers in congenital disorders of glycosylation consortium, a cross-sectional study report at year 5 of 280 individuals in the natural history cohort. Mol Genet Metab. 2024 08; 142(4):108509.
-
N-glycoproteomic analyses of human intestinal enteroids, varying in histo-blood group geno- and phenotypes, reveal a wide repertoire of fucosylated glycoproteins. Glycobiology. 2024 04 24; 34(6).